Billionaire Philippe Laffont sold Nvidia, AMD and invested heavily in two companies dominating a market that may reach beyond $100 billion; which are the stocks?

Founder of Coatue Management Philippe Laffont, known for his innovative technology investment portfolio has recently reduced his holdings in two AI chip giants, Nvidia and AMD, as per reports. Find out where he is now investing.

A boom in the drug market

Laffont turned his attention to the booming weight loss drug sector, according to The Motley Fool report.

By cutting his investments in Nvidia and AMD, he boosted his investments in Eli Lilly and Novo Nordisk. These two pharmaceutical companies are currently dominating the weight loss drug market


Also Read : Is there a connection between women's health during pregnancy and autism? This study debunks myth

Diversifying investments

He has increased his stake in Lilly to more than 19%. Laffont now holds 247,950 shares, according to the report. He increased his stake in Novo Nordisk to more than 800%. According to the report, Laffont now owns 326,363 shares.

According to analysts, the drug market could reach between $100 billion to $130 billion by 2030, reported The Motley Fool. This is a win-win situation for the companies and for investors to benefit from the company's growth.

Eli Lilly and Novo Nordisk are proving to be strong growth stocks, with high demand for weight loss drugs—Mounjaro and Zepbound from Lilly, and Ozempic and Wegovy from Novo. These drugs target hormones involved in blood sugar and appetite regulation, offering significant weight loss benefits.

Eli Lilly’s Zepbound just got approval for sleep apnea, which could increase accessibility through Medicare. Meanwhile, Medicare already covers Wegovy for heart risk reduction, broadening its reach. With blockbuster sales and growing market potential, Laffont’s investment in these pharma giants looks like a savvy move for long-term growth, as per the report.

Also Read : Massive valuation: OpenAI in talks to raise up to $40 billion that would value ChatGPT owner at a whopping $340 billion, says report

Laffont hasn’t completely walked away from Nvidia and AMD. Laffont reduced his Nvidia stake by 26% to about 10 million shares and cut his AMD holding by 32% to 4.2 million shares, as per the report. While still confident in their future, Laffont is diversifying into new areas for growth.

FAQs

Why did Philippe Laffont reduce his holdings in Nvidia and AMD?
Laffont reduced his positions to diversify his portfolio and explore growth in new sectors, particularly the weight loss drug market.

What companies is Laffont now investing in?
Laffont increased his investments in Eli Lilly and Novo Nordisk, betting on their dominance in the rapidly growing weight loss drug market.